ロード中...
Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines
Antigen-specific immunotherapy using DNA vaccines has emerged as an attractive approach for the control of tumors. Another novel cancer therapy involves the employment of the vascular disrupting agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA). In the current study, we aimed to test the combinati...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3062584/ https://ncbi.nlm.nih.gov/pubmed/21385449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1423-0127-18-21 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|